Added to YB: 2026-09-30
Pitch date: 2026-09-25
BAYN.DE [neutral]
Bayer Aktiengesellschaft
-11.99%
current return
Author Info
No bio for this author
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 49.9B
Pitch Price
EUR 50.46
Price Target
N/A
Dividend
0.22%
EV/EBITDA
8.00
P/E
-28.72
EV/Sales
1.84
Sector
Pharmaceuticals
Category
special_situation
BAYN – Hybrid bond issuance
BAYN.DE (update): Bayer raised €2bn through hybrid bonds with six- and nine-year non-call periods, lifting outstanding hybrids to €6.55bn and helping bolster its finances ahead of anticipated litigation payouts. Both tranches were roughly 4x oversubscribed and priced 50bps inside initial guidance, at 5.75% and 6.25% coupons. The shares trade at 9.4x 2028 earnings and yield 2.0%, while the proposed $7.25bn glyphosate settlement remains pending.
Read full article (1 min)